Pfizer begins Phase 3 trial of RSV vaccine in adults Ruchika Sharma5 Sept 2021 4:30 AMNew York: Pfizer Inc. has recently announced the initiation of RENOIR (RSV vaccine Efficacy study iN Older adults Immunized against RSV disease), a...
Johnson and Johnson Rilematovir gets CDSCO panel okay for phase 3 trial Medical Dialogues Team18 Aug 2021 10:48 AMNew Delhi: Global pharmaceuticals major Johnson and Johnson (JnJ) has got a go ahead from the Subject Expert Committee (SEC) of the Central Drugs...
Two COVID-19 vaccines exhibit Safety and strong immunity in infant model Hina Zahid17 Jun 2021 5:45 AMThe research, published June 15 in Science Immunology, suggests that vaccines for young children are likely important, safe tools to curtail the...
Bronchiolitis in infants has different subtypes with differing risks of asthma: Study Hina Zahid17 Jun 2021 5:06 AMOur data add significant support to the emerging concept that bronchiolitis represents several diseases with unique biological mechanisms. USA:...
Study predicts which kids hospitalized with respiratory syncytial virus likely to worsen Hina Zahid12 April 2021 1:00 PMChildren hospitalized with breathing problems due to a common viral lung infection are likely to get sicker and remain hospitalized if they have high...
GSK to launch final testing of respiratory syncytial virus vaccine Ruchika Sharma21 Oct 2020 5:30 AMGSK said Phase III studies, with the potential to produce data for regulatory approval, would likely start over the coming months.
Pfizer starts Four Phase 3 Clinical Trials for Investigational Vaccines Ruchika Sharma25 Jun 2020 3:30 AMNew York: Pfizer Inc. has announced the initiation of four Phase 3 clinical trials within its current pipeline of investigational vaccines:Two studies...
